top of page


Thomas Kaiser Talks Pill Penalty, North Carolina, and the Realities of Drug Development on Making Medicine
On the latest episode of the Making Medicine podcast, Incubate executive director John Stanford sat down with Thomas Kaiser of Avicenna...
Incubate Coalition
Apr 16


Incubate Releases Statement on President Trump's Executive Order to Undo the Pill Penalty
WASHINGTON ( April 16) -- Yesterday, President Trump issued an executive order calling on Secretary of Health and Human Services Robert...
Incubate Coalition
Apr 16


Incubate Executive Director Joins The Hill's Roundtable on the EPIC Act
On March 26, Incubate executive director John Stanford joined a roundtable discussion hosted by The Hill and the Alliance for Aging...
Incubate Coalition
Apr 2


Incubate in PharmaVoice on Why Lawmakers Must Fix the Small Molecule Penalty
Incubate executive director John Stanford was recently featured in a PharmaVoice article by reporter Amy Baxter on proposed reforms to...
Incubate Coalition
Mar 18


Incubate in BioWorld on How the EPIC Act Would Restore Investment in Small Molecules
BioWorld regulatory editor Mari Serebrov recently interviewed Incubate's executive director John Stanford for her article on how the...
Incubate Coalition
Mar 12


Incubate in Endpoints News on the Importance of the EPIC Act
Incubate executive director John Stanford was recently featured in an Endpoints News article by senior editor Zachary Brennan on...
Incubate Coalition
Mar 12


Incubate applauds introduction of EPIC Act in the Senate
WASHINGTON, D.C. (March 5, 2025) -- This week, Senators Thom Tillis (R-NC), Ted Budd (R-NC), Marsha Blackburn (R-TN), James Lankford...
Incubate Coalition
Mar 5


New Data Shows More Life Sciences Research Programs and Drugs Are Being Discontinued
We recently tallied six new entries for our Life Sciences Investment Tracker , identifying four more research programs and two more drugs...
Incubate Coalition
Mar 5


Incubate Featured in STAT's Coverage of the EPIC Act Introduction
STAT reporter Ed Silverman recently interviewed Incubate's execute director John Stanford for an article on the EPIC Act's...
Incubate Coalition
Mar 5


Looking back and looking ahead: A momentous (and misguided) time for drug pricing policy
August was a momentous month for the life sciences ecosystem, and September looks to be just as significant. In this blog post, we want...
Incubate Coalition
Sep 20, 2024


Life Sciences Investors Applaud Bipartisan Bill To Eliminate Small-Molecule Penalty
This bipartisan legislation would eliminate the small-molecule penalty by aligning the price-setting timeline for small and large...
Incubate Coalition
Feb 1, 2024
bottom of page